Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
1.
Br J Surg ; 106(12): 1602-1610, 2019 11.
Article in English | MEDLINE | ID: mdl-31573086

ABSTRACT

BACKGROUND: A survival benefit of extensive intraoperative peritoneal lavage (EIPL) has been reported in patients with gastric cancer with positive peritoneal cytology. The hypothesis of this study was that EIPL may reduce peritoneal recurrence in patients with advanced gastric cancer who undergo surgery with curative intent. METHODS: This was an open-label, multi-institutional, randomized, phase 3 trial to assess the effects of EIPL versus standard treatment after curative gastrectomy for resectable gastric cancer of T3 status or above. The primary endpoint was disease-free survival (DFS); secondary endpoints were overall survival, peritoneal recurrence-free survival and incidence of adverse events. RESULTS: Between July 2011 and January 2014, 314 patients were enrolled from 15 institutions and 295 patients were analysed (145 and 150 in the EIPL and no-EIPL groups respectively). The 3-year DFS rate was 63·9 (95 per cent c.i. 55·5 to 71·2) per cent in the EIPL group and 59·7 (51·3 to 67·1) per cent in the control group (hazard ratio (HR) 0·81, 95 per cent c.i. 0·57 to 1·16; P = 0·249). The 3-year overall survival rate was 75·0 (67·1 to 81·3) per cent in the EIPL group and 73·7 (65·9 to 80·1) per cent in the control group (HR 0·91, 0·60 to 1·37; P = 0·634). Peritoneal recurrence-free survival was not significantly different between the two groups (HR 0·92, 0·62 to 1·36; P = 0·676). No intraoperative complications related to EIPL were observed. CONCLUSION: EIPL did not improve survival or peritoneal recurrence in patients who underwent gastrectomy for advanced gastric cancer. Registration number: 000005907 (http://www.umin.ac.jp/ctr/index.htm).


ANTECEDENTES: Se ha descrito que un lavado peritoneal extenso intraoperatorio (extensive intraoperative peritoneal lavage, EIPL) proporciona un beneficio en la supervivencia en pacientes con cáncer gástrico con citología peritoneal positiva. La hipótesis de este estudio era que el EIPL podría disminuir la recidiva peritoneal en pacientes con cáncer gástrico avanzado sometidos a cirugía con intención curativa. MÉTODOS: Ensayo clínico fase 3, abierto, multicéntrico y aleatorizado para evaluar los efectos de un lavado peritoneal extenso intraoperatorio (EIPL) frente a tratamiento estándar tras gastrectomía curativa por cáncer gástrico ≥T3 resecable. La variable de resultado primaria fue la supervivencia libre de enfermedad (disease-free survival, DFS), y las variables de resultado secundarias fueron la supervivencia global (overall survival, OS), la supervivencia libre de recidiva peritoneal y la incidencia de efectos adversos. RESULTADOS: Entre julio de 2011 y enero de 2014, se reclutaron 314 pacientes de 15 instituciones y se analizaron los datos de 295 pacientes (145 en el grupo con EIPL y 150 en el grupo sin EIPL). La DFS a los 3 años fue 63,9% (i.c. del 95% 55,5-71,2) en el grupo con EIPL y 59,7% (i.c. del 95% 51,3-67,1) en el grupo control (cociente de riesgos instantáneos, hazard ratio, HR 0,81 (i.c. del 95% 0,57-1,16), P = 0,249). La OS a los 3 años fue 75,0% (i.c. del 95% 67,1-81,3) en el grupo con EIPL y 73,7% (i.c. del 95% 65,9-80,1) en el grupo control (HR 0,91 i.c. del 95% 0,60-1,37), P = 0,634). No se observaron diferencias estadísticamente significativas entre los dos grupos en la supervivencia libre de recidiva peritoneal (P = 0,676, HR 0,92 (i.c. del 95% 0,62-1,36). No se observaron complicaciones intraoperatorias relacionadas con EIPL. CONCLUSIÓN: El EIPL no mejoró la supervivencia o la recidiva peritoneal en pacientes sometidos a gastrectomía por cáncer gástrico avanzado.


Subject(s)
Adenocarcinoma/surgery , Gastrectomy , Intraoperative Care , Peritoneal Lavage , Stomach Neoplasms/surgery , Adenocarcinoma/drug therapy , Adenocarcinoma/mortality , Adenocarcinoma/secondary , Aged , Chemotherapy, Adjuvant , Disease-Free Survival , Female , Humans , Male , Middle Aged , Peritoneal Neoplasms/secondary , Recurrence , Stomach Neoplasms/drug therapy , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology
2.
Oncogene ; 34(13): 1679-87, 2015 Mar 26.
Article in English | MEDLINE | ID: mdl-24747971

ABSTRACT

Small cell lung carcinoma (SCLC) often features the upregulation of the Sonic hedgehog (Shh) pathway leading to activation of Gli transcription factors. SCLC cells secrete bombesin (BBS)-like neuropeptides that act as autocrine growth factors. Here, we show that SCLC tumor samples feature co-expression of Shh and BBS-cognate receptor (gastrin-releasing peptide receptor (GRPR)). We also demonstrate that BBS activates Gli in SCLC cells, which is crucial for BBS-mediated SCLC proliferation, because cyclopamine, an inhibitor of the Shh pathway, hampered the BBS-mediated effects. BBS binding to GRPR stimulated Gli through its downstream Gαq and Gα12/13 GTPases, and consistently, other Gαq and Gα13 coupled receptors (such as muscarinic receptor, m1, and thrombin receptor, PAR-1) and constitutively active GαqQL and Gα12/13QL mutants stimulated Gli. By using cells null for Gαq and Gα12/13, we demonstrate that these G proteins are strictly necessary for Gli activation by BBS. Moreover, by using constitutively active Rho small G-protein (Rho QL) as well as its inhibitor, C3 toxin, we show that Rho mediates G-protein-coupled receptor (GPCR)-, Gαq- and Gα12/13-dependent Gli stimulation. At the molecular level, BBS caused a significant increase in Shh gene transcription and protein secretion that was dependent on BBS-induced GPCR/Gαq-12/13/Rho mediated activation of nuclear factor κB (NFκB), which can stimulate a NF-κB response element in the Shh gene promoter. Our data identify a novel molecular network acting in SCLC linking autocrine BBS and Shh circuitries and suggest Shh inhibitors as novel therapeutic strategies against this aggressive cancer type.


Subject(s)
Hedgehog Proteins/physiology , Lung Neoplasms/pathology , Receptors, Bombesin/physiology , Signal Transduction/physiology , Small Cell Lung Carcinoma/pathology , Animals , Bombesin/pharmacology , Boronic Acids/pharmacology , Bortezomib , Cisplatin/pharmacology , GTP-Binding Protein alpha Subunits, G12-G13/physiology , GTP-Binding Protein alpha Subunits, Gq-G11/physiology , HEK293 Cells , Humans , Lung Neoplasms/drug therapy , Mice , NIH 3T3 Cells , Oncogene Proteins/physiology , Pyrazines/pharmacology , Small Cell Lung Carcinoma/drug therapy , Trans-Activators/physiology , Zinc Finger Protein GLI1
3.
Endosc Ultrasound ; 3(Suppl 1): S4-5, 2014 Apr.
Article in English | MEDLINE | ID: mdl-26425529

ABSTRACT

INTRODUCTION: We report a case of low-risk stomach gastrointestinal stromal tumor (GIST) which has been under a long-term observation, obtaining from this experience knowledge useful in determining the treatment formula for this disease. RESULTS: During the observation for 6 years, no such change as ulcer formation was observed in the appearance of the tumor. The measurement of tumor diameter, however, showed gradual growth of maximum tumor diameter from 2.7 to 5.0 cm. When the changes in the diameter of tumor during this period is plotted, taking the timeon the horizontal axis and the tumor diameter on the vertical axis, the growth of the tumor can be approximated with a secondary function, making it possible to estimate the developmental period of the GIST concerned from the approximated secondary function. Thus, the developmental period in this case was estimated to go back 19 years before the time when it was discovered for the 1(st) time. Further, it was considered that the coefficient of the secondary function represents the rate of tumor growth, and that comparison with this coefficient contributed to the evaluation of malignancy stage of the GIST concerned. CONCLUSION: The growth curve predicting the growth of tumor could be depicted by measuring the diameter of the tumor in GIST twice or more at an interval of 6-12 months with EUS, and it was thought that this was utilizable for determining treatment formula for GISTs.

4.
Endosc Ultrasound ; 3(Suppl 1): S7, 2014 Apr.
Article in English | MEDLINE | ID: mdl-26425534

ABSTRACT

Aberrant pancreas is used to describe ectopic pancreatic tissue lying outside its normal location with no anatomic or vascular connection to the pancreas proper. Patients with aberrant pancreas are usually asymptomatic, so aberrant pancreas are typically discovered incidentally during endoscopy, surgery, or autopsy. This time, we report a case of gastric aberrant pancreas bleeding was repeated and endoscopic hemostasis was difficult. A 22-year-old man was admitted to a hospital with a complaint of epigastric pain and melena. Upper gastrointestinal endoscopy and endoscopic ultrasonography (EUS) revealed a submucosal tumor with a bleeding ulcer at the anterior wall of the antrum in the stomach, and diagnosed it as an aberrant pancreas. It was hard to stop bleeding by in total 7 times endoscopic hemostasis and anemia was gradually progressed, so partial gastrectomy was performed. This gastric tumor measured 40 mm × 30 mm × 20 mm and had a severe ulcerative change. The pathological diagnosis was aberrant pancreas with Langerhans islet, acinous cells and excretory duct. (Heinrich type) Until December 2013 in Japan, 13 cases of gastric aberrant pancreas with bleeding have been reported and in these, a surgery was done in 11 cases. In gastric aberrant pancreas cases with ulcer formation like this case, endoscopic hemostasis is expected to be difficult, and surgery is necessary. Hence, early accurate diagnosis by EUS is a very important to decide better treatment plan.

5.
Clin Lab Haematol ; 28(4): 262-6, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16898967

ABSTRACT

This is a case report of granulocytic sarcoma occurring as a nasal lesion prior to the onset of acute myelogenous leukaemia (AML). To understand this case in more detail, we used 40,000 human cDNA microarray to identify the gene expression patterns of nonleukaemic stage bone marrow (BM), AML stage BM and AML stage peripheral blood cells and subsequently define the molecular basis of this disease progression. Of significance, we have tracked the expression profile of BM samples during the course of nonleukaemic to leukaemic progression, and identified a number of genes that may account for the growth potential of leukaemia cells and indicate poor prognosis of this case.


Subject(s)
Gene Expression Regulation, Leukemic/genetics , Leukemia, Myeloid, Acute/genetics , Nose Neoplasms/genetics , Sarcoma, Myeloid/genetics , Aged, 80 and over , Disease Progression , Down-Regulation/genetics , Fatal Outcome , Female , Humans , Leukemia, Myeloid, Acute/pathology , Nose Neoplasms/pathology , Oligonucleotide Array Sequence Analysis/methods , Sarcoma, Myeloid/pathology , Up-Regulation/genetics
6.
J Pediatr Surg ; 36(11): 1675-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11685700

ABSTRACT

PURPOSE: Thyroid receptor alpha-1 (TR-alpha1) and thyroid receptor beta-1 (TR-beta1) are thought to be essential for the fetal and postnatal development of the lung. The authors investigated gene level expression of TR-alpha1 and TR-beta1 in the lung of nitrofen-induced congenital diaphragmatic hernia (CDH) using reverse transcription polymerase chain reaction (RT-PCR). METHODS: CDH was induced in pregnant rats after administration of 100 mg nitrofen on day 9.5 of gestation. Cesarean section was performed on day 21 of gestation. The fetuses were divided into 3 groups: normal controls (n = 16), nitrofen-induced CDH (n = 16), and nitrofen-treated without CDH (n = 16). mRNA was extracted from the left lung in each group. RT-PCR was performed to evaluate mRNA expressions of TR-alpha1 and TR-beta1. Levels of mRNA were expressed as a ratio of the band density divided by that of beta-actin, a house-keeping gene. RESULTS: TR-alpha1 mRNA expression was decreased significantly in CDH lung (1.618 +/- 0.148) compared with controls (2.658 +/- 0.251; P <.01) and nitrofen-treated without CDH lung (2.232 +/- 0.193; (P <.05). TR-beta1 mRNA expression also was significantly decreased in CDH lung (2.223 +/- 0.270) compared with controls (3.569 +/- 0.262; P <.01) and nitrofen-treated without CDH lung (3.235 +/- 0.299; P <.05). CONCLUSION: These data suggest that the downregulation of thyroid hormone signaling pathway through altered expression of TR-alpha1 and TR-beta1 during lung morphogenesis may be a contributory factor in the pathogenesis of pulmonary hypoplasia in nitrofen-induced CDH.


Subject(s)
Gene Expression , Hernia, Diaphragmatic/metabolism , Lung/abnormalities , Lung/metabolism , RNA, Messenger/metabolism , Receptors, Thyroid Hormone/metabolism , Animals , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Female , Herbicides , Hernia, Diaphragmatic/chemically induced , Hernia, Diaphragmatic/genetics , Lung/embryology , Morphogenesis , Phenyl Ethers , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Thyroid Hormone/genetics , Reverse Transcriptase Polymerase Chain Reaction
7.
Int J Oncol ; 19(5): 971-6, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11604996

ABSTRACT

Mutations of the Kristen ras (K-ras) gene have been implicated in the pathogenesis of human lung cancer, especially adenocarcinoma, and have been proposed to be a prognostic factor. The K-ras mutation in codon 12 is detectable even in cell-free fluids by using the enriched polymerase chain reaction (PCR) technique. On the other hand, based on experimental results, the rho A mutation in codon 14 is also proposed to be oncogenic as observed in the K-ras mutation. Malignant pleural effusion is a common complication of lung cancer. We studied the point mutation of K-ras codon 12 and rho A codon 14 using enriched PCR in specimens of pleural effusion. Forty patients with pleural effusion were enrolled in this study. The causes of pleural effusion were non-small cell lung cancer (18 cases), small cell lung cancer (6 cases), malignant mesothelioma (2 cases), metastatic lung tumor (5 cases), thymoma (1 case), malignant lymphoma (1 case), and pleuritis tuberculosa (7 cases). The K-ras mutation was detected in 4 of 14 cases with adenocarcinoma, 1 of 3 cases with squamous cell carcinoma, 1 of 1 case with large cell carcinoma, and 1 of 5 cases with metastatic lung tumor, respectively. The rho A mutation was not detected in any pleural effusion examined in this study. Our study demonstrates the usefullness of pleural effusion as a clinical specimen for a search of point mutation of oncogenes. The K-ras codon 12 mutation is readily detected in pleural effusion, and the demonstration of this mutation has potentially important implications for the diagnosis of malignant pleural effusion.


Subject(s)
Genes, ras/genetics , Pleural Effusion, Malignant/genetics , Point Mutation , rhoA GTP-Binding Protein/genetics , Adult , Aged , Carcinoma, Small Cell/genetics , Codon/genetics , DNA Primers , DNA, Neoplasm/analysis , Female , Humans , Lung Neoplasms/genetics , Lymphoma/genetics , Male , Mesothelioma/genetics , Middle Aged , Pleural Effusion, Malignant/diagnosis , Polymerase Chain Reaction , Prognosis , Thymoma/genetics , Tuberculosis/genetics
8.
Int J Oncol ; 19(5): 1035-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11605006

ABSTRACT

Retinoblastoma (RB) protein and antibody against RB protein in sera from 45 lung cancer patients and 30 healthy volunteers were examined using bacterially synthesized glutathione S-transferase (GST) RB fusion protein and immunoblot analysis. RB protein was not detected in sera from any individuals with lung cancer or in any healthy volunteers. Sera from 6 patients, including 4 with non-small cell carcinoma and 2 with small cell carcinoma, reacted to a GST-RB fusion protein but not with a GST protein. Sera from 30 normal volunteers reacted to neither GST-RB fusion protein nor GST protein. The backgrounds such as age, gender, performance status, histology, stage, smoking history, and prior treatment were not significantly different between the patients with and without anti-RB antibodies. This is the first report describing the presence of anti-RB antibody in patients with malignant tumors. Further studies are needed to establish clinical significance for anti-RB antibody.


Subject(s)
Autoantibodies/blood , Carcinoma, Non-Small-Cell Lung/immunology , Carcinoma, Small Cell/immunology , Lung Neoplasms/immunology , Retinoblastoma Protein/immunology , Adult , Aged , DNA Primers/chemistry , Female , Glutathione Transferase/genetics , Humans , Male , Middle Aged , Neoplasm Staging , Recombinant Fusion Proteins/immunology , Reverse Transcriptase Polymerase Chain Reaction
9.
Respir Physiol ; 127(2-3): 105-11, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11504583

ABSTRACT

Positive-pressure mechanical ventilation can injure the lung, causing edema and alveolar inflammation in a complication termed ventilator-induced lung injury (VILI). Cytokines such as interleukin-8 (IL-8) reportedly are important in this inflammatory response. On the other hand, hepatocyte growth factor (HGF) promotes regeneration of the lung, and delays pulmonary fibrosis. We postulated that cyclic stretch upregulates production and release of both of mediators. Human alveolar epithelial cells (A549) cultured on a silicoelastic membrane were tested for mRNA expression and release of IL-8 and HGF after cyclic stretch in vitro. Stretch induced mRNA expression and release of these mediators. The signaling pathway from cyclic stretch to release of IL-8 and HGF appeared to involve protein kinase C in the signal transduction pathway.


Subject(s)
Epithelial Cells/enzymology , Hepatocyte Growth Factor/genetics , Interleukin-8/genetics , Protein Kinase C/metabolism , Pulmonary Alveoli/cytology , Cells, Cultured , Enzyme Inhibitors/pharmacology , Epithelial Cells/cytology , Gene Expression/physiology , Humans , Peptides/pharmacology , Protein Kinase C/antagonists & inhibitors , Pulmonary Edema/metabolism , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Stress, Mechanical
10.
Plant Cell Physiol ; 42(8): 849-56, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11522911

ABSTRACT

The Lhcb gene family in green plants encodes several light-harvesting Chl a/b-binding (LHC) proteins that collect and transfer light energy to the reaction centers of PSII. We comprehensively characterized the Lhcb gene family in the unicellular green alga, Chlamydomonas reinhardtii, using the expressed sequence tag (EST) databases. A total of 699 among over 15,000 ESTs related to the Lhcb genes were assigned to eight, including four new, genes that we isolated and sequenced here. A sequence comparison revealed that six of the Lhcb genes from C. reinhardtii correspond to the major LHC (LHCII) proteins from higher plants, and that the other two genes (Lhcb4 and Lhcb5) correspond to the minor LHC proteins (CP29 and CP26). No ESTs corresponding to another minor LHC protein (CP24) were found. The six LHCII proteins in C. reinhardtii cannot be assigned to any of the three types proposed for higher plants (Lhcb1-Lhcb3), but were classified as follows: Type I is encoded by LhcII-1.1, LhcII-1.2 and LhcII-1.3, and Types II, III and IV are encoded by LhcII-2, LhcII-3 and LhcII-4, respectively. These findings suggest that the ancestral LHC protein diverged into LHCII, CP29 and CP26 before, and that LHCII diverged into multiple types after the phylogenetic separation of green algae and higher plants.


Subject(s)
Algal Proteins/genetics , Chlamydomonas reinhardtii/genetics , Light-Harvesting Protein Complexes , Photosynthetic Reaction Center Complex Proteins/genetics , Photosystem II Protein Complex , Plant Proteins/genetics , Algal Proteins/chemistry , Algal Proteins/isolation & purification , Amino Acid Sequence , Animals , Biological Evolution , Chlamydomonas reinhardtii/metabolism , Chlorophyll/metabolism , Chlorophyll A , Chlorophyll Binding Proteins , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Expressed Sequence Tags , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Molecular Sequence Data , Multigene Family , Phylogeny , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Messenger/radiation effects , Sequence Homology, Amino Acid
11.
Pediatr Surg Int ; 17(4): 284-7, 2001 May.
Article in English | MEDLINE | ID: mdl-11409163

ABSTRACT

Newborns with congenital diaphragmatic hernia (CDH) still have high mortality. Recently, a possible role of cardiac maldevelopment has been suggested. Human and experimental studies have demonstrated that heart weight is significantly reduced in the presence of CDH. Recent studies have suggested an important role for insulin-like growth factor-I (IGF-I) in the regulation of cardiac growth, structure, and function. Administration of IGF-I to normal rats has been shown to cause cardiac hypertrophy. Epidermal growth factor (EGF) plays an important role in cardiac differentiation and development. The aim of this study was to determine the gene-level expression of IGF-I and EGF in the hearts of rats with nitrofen-induced CDH using the reverse-transcription polymerase chain reaction technique (RT-PCR). CDH was induced in pregnant rats following administration of 100 mg nitrofen on day 9.5 of gestation (term 22 days). In control animals, the same dose of olive oil was given without nitrofen. Cesarean section was performed on day 21 of gestation. The fetuses were divided into three groups: normal controls (n = 8), nitrofen without CDH (n = 8), and nitrofen-induced CDH (n = 8). Total RNA was extracted from the hearts in each group and measured. mRNA was extracted from total RNA. RT-PCR was performed to evaluate mRNA expressions of IGF-I and EGF. Levels of mRNA were expressed as a ratio of band density divided by that of beta-actin, a housekeeping gene known to be expressed at a constant level. IGF-I mRNA expression was significantly decreased in CDH hearts (0.177 +/- 0.109) compared to controls (0.393 +/- 0.138) (P < 0.01) and nitrofen hearts without CDH (0.321 +/- 0.088) (P < 0.05). EGF mRNA expression was significantly decreased in CDH hearts (0.218 +/- 0.118) compared to controls (0.534 +/- 0.196) (P < 0.01) and nitrofen hearts without CDH (0.383 +/- 0.136) (P < 0.05). Decreased cardiac gene expression of IGF-I and EGF in the hypoplastic heart suggests that cardiac hypoplasia in nitrofen-induced rat CDH may be due to reduced synthesis of IGF-I and EGF by myocytes in the developing heart.


Subject(s)
Down-Regulation/genetics , Epidermal Growth Factor/genetics , Fetal Diseases/chemically induced , Fetal Diseases/genetics , Gene Expression/physiology , Heart/physiopathology , Hernia, Diaphragmatic/chemically induced , Hernia, Diaphragmatic/genetics , Hypoplastic Left Heart Syndrome/genetics , Insulin-Like Growth Factor I/genetics , Pesticides/adverse effects , Phenyl Ethers/adverse effects , RNA, Messenger/genetics , Animals , Disease Models, Animal , Female , Hernias, Diaphragmatic, Congenital , Hypoplastic Left Heart Syndrome/physiopathology , Pregnancy , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
12.
J Biol Chem ; 275(34): 26441-8, 2000 Aug 25.
Article in English | MEDLINE | ID: mdl-10840034

ABSTRACT

The Ras guanine-nucleotide exchange factor Ras-GRF/Cdc25(Mn) harbors a complex array of structural motifs that include a Dbl-homology (DH) domain, usually found in proteins that interact functionally with the Rho family GTPases, and the role of which is not yet fully understood. Here, we present evidence that Ras-GRF requires its DH domain to translocate to the membrane, to stimulate exchange on Ras, and to activate mitogen-activated protein kinase (MAPK). In an unprecedented fashion, we have found that these processes are regulated by the Rho family GTPase Cdc42. We show that GDP- but not GTP-bound Cdc42 prevents Ras-GRF recruitment to the membrane and activation of Ras/MAPK, although no direct association of Ras-GRF with Cdc42 was detected. We also demonstrate that catalyzing GDP/GTP exchange on Cdc42 facilitates Ras-GRF-induced MAPK activation. Moreover, we show that the potentiating effect of ionomycin on Ras-GRF-mediated MAPK stimulation is also regulated by Cdc42. These results provide the first evidence for the involvement of a Rho family G protein in the control of the activity of a Ras exchange factor.


Subject(s)
Mitogen-Activated Protein Kinases/metabolism , cdc42 GTP-Binding Protein/physiology , ras-GRF1/metabolism , 3T3 Cells , Animals , COS Cells , Cell Membrane/metabolism , Enzyme Activation , Guanosine Diphosphate/metabolism , Guanosine Triphosphate/metabolism , Ionomycin/pharmacology , Ionophores/pharmacology , Mice , Structure-Activity Relationship
13.
Biochem Biophys Res Commun ; 272(3): 717-20, 2000 Jun 16.
Article in English | MEDLINE | ID: mdl-10860821

ABSTRACT

Cells organize diverse types of specialized adhesion sites upon attachment to extracellular matrix (ECM) components. One of the physiological roles of such cell-ECM interactions is to initiate and regulate adhesion-mediated signal transduction responses. The association of cells with fibronectin fibrils has been shown to regulate the JNK and p38 signaling pathways. We tested whether tensin, a cytoskeletal component localized to both focal contacts and fibronectin-associated fibrillar adhesions, can induce these signaling pathways. We found that tensin overexpression resulted in activation of both the c-Jun amino-terminal kinase (JNK) and p38 pathways. Tensin-mediated JNK activation was independent of the activities of the small GTP binding proteins Rac and Cdc42, but did depend on SEK, a kinase involved in the JNK pathway. We suggest that tensin may directly activate the JNK and p38 pathways, acting downstream or independent of the activities of the small GTP binding proteins Rac and Cdc42.


Subject(s)
MAP Kinase Kinase 4 , MAP Kinase Signaling System , Microfilament Proteins/metabolism , Mitogen-Activated Protein Kinases/metabolism , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Enzyme Activation , Focal Adhesion Kinase 1 , Focal Adhesion Protein-Tyrosine Kinases , Genes, Dominant/genetics , Humans , JNK Mitogen-Activated Protein Kinases , MAP Kinase Kinase 6 , Microfilament Proteins/genetics , Mitogen-Activated Protein Kinase Kinases/genetics , Mitogen-Activated Protein Kinase Kinases/metabolism , Mitogen-Activated Protein Kinases/genetics , Models, Biological , Mutation/genetics , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tensins , Transfection , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism , p38 Mitogen-Activated Protein Kinases , rac GTP-Binding Proteins/genetics , rac GTP-Binding Proteins/metabolism
14.
Plant Cell Physiol ; 40(10): 1087-92, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10589522

ABSTRACT

CRR12 was identified as a cytokinin-repressed gene encoding a cucumber homologue for a basic region/helix-loop-helix protein. The level of CRR12 mRNA decreased in response to either cytokinins or light in etiolated cotyledons. The level was low in cotyledons and leaves of light-grown plants, but it increased during dark incubation.


Subject(s)
Cucumis sativus/chemistry , Cucumis sativus/genetics , Cytokinins/genetics , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Plants, Edible/chemistry , Plants, Edible/genetics , Transcription Factors/chemistry , Transcription Factors/genetics , Amino Acid Sequence , Basic Helix-Loop-Helix Transcription Factors , Blotting, Northern , Cloning, Molecular , DNA, Complementary/chemistry , Molecular Sequence Data , Photic Stimulation , Plant Growth Regulators/pharmacology , Plants/chemistry , Plants/genetics , RNA, Messenger/analysis , RNA, Messenger/metabolism
15.
No To Shinkei ; 51(9): 799-803, 1999 Sep.
Article in Japanese | MEDLINE | ID: mdl-10511958

ABSTRACT

We report a 30-year-old man with acute disseminated encephalomyelitis (ADEM) accompanying Mycoplasma pneumoniae (M. pneumoniae) infection. He was admitted to our hospital because of headache, disturbed behavior, and unconsciousness following an upper respiratory tract infection on December 19, 1996. On admission, he was febrile (37.3 degrees C) and showed hypersomnia and neck stiffness. There were scattered rhonchi in both lungs. Cerebrospinal fluid (CSF) contained 19 white cells; the protein was 20 mg/dl and glucose 71 mg/dl (blood glucose 170 mg/dl); no organisms were seen or cultured. Cranial MRI showed multiple T 2-weighted hyperintense in the periventricular region of the cerebral white matter. M. pneumoniae antibody titer in serum was remarkably elevated. ADEM related to M. pneumoniae was suspected. Although intravenous methylprednisolone, piperacillin and clindamycin were administered, there was no subsequent improvement in the symptoms. Further MRI scan revealed extension of the inflammatory lesion. He had both pneumonia and he required mechanical ventilation. Since the end of the critical period, he has been in an akinetic mutism. We conclude that M. pneumoniae has to be considered as a possible cause of ADEM with severe respiratory symptoms.


Subject(s)
Encephalomyelitis, Acute Disseminated/etiology , Pneumonia, Mycoplasma/complications , Adult , Encephalomyelitis, Acute Disseminated/diagnosis , Humans , Male , Prognosis
17.
Oncogene ; 17(8): 991-8, 1998 Aug 27.
Article in English | MEDLINE | ID: mdl-9747878

ABSTRACT

The small GTP-binding Rho proteins control a variety of biological activities, including organization of the actin cytoskeleton, regulation of gene expression and cellular transformation. In contrast, Ras proteins do not induce actin stress fibers, but potently transform cells which exhibit a morphology clearly distinct from that caused by activated forms of Rho. To investigate whether nuclear signaling and oncogenic potential of Rho are a consequence of its profound effect on cytoskeletal organization, we replaced each amino acid in the Rho effector loop with those of Ras, or replaced conserved residues with others known to result in differential signaling capability when introduced into Ras and Rac1. These Rho mutants did not gain the ability to induce the MAPK, JNK or p38 pathways but, surprisingly, all Rho effector loop mutants still continued to induce actin stress fiber formation. However, three of these Rho mutants, with substitutions of leucine-39, glutamic acid-39, or cysteine-42, lost the ability to stimulate gene transcription via the serum response factor (SRF) and failed to induce neoplastic transformation. Thus, these results indicate that cytoskeletal changes are not sufficient to induce the transformed phenotype, and that Rho-effector molecules regulating the actin cytostructure are distinct from those signaling to the nucleus and subverting normal growth control.


Subject(s)
Cell Transformation, Neoplastic/metabolism , Cytoskeleton/metabolism , GTP-Binding Proteins/genetics , GTP-Binding Proteins/metabolism , Mitogen-Activated Protein Kinases , Mutagenesis , Nuclear Localization Signals/genetics , 3T3 Cells , Amino Acid Sequence , Animals , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Cell Transformation, Neoplastic/genetics , Cytoskeleton/physiology , Dogs , GTP Phosphohydrolases/genetics , GTP Phosphohydrolases/metabolism , GTP-Binding Proteins/physiology , JNK Mitogen-Activated Protein Kinases , Kidney , Mice , Mice, Nude , Molecular Sequence Data , Nuclear Localization Signals/physiology , Protein Structure, Tertiary , Transfection , p38 Mitogen-Activated Protein Kinases , rac GTP-Binding Proteins , ras Proteins/genetics , ras Proteins/metabolism
18.
Rinsho Shinkeigaku ; 38(1): 32-7, 1998 Jan.
Article in Japanese | MEDLINE | ID: mdl-9597907

ABSTRACT

A 62-year-old woman with pulmonary tuberculosis was admitted to our hospital. She was completely neurologically free at admission and her CSF was normal. Brain MRI with Gd-DTPA enhancement demonstrated two mass lesions with ring-enhancement in the left temporal lobe and the right frontal lobe. The left temporal lesion had a bright central core with hypointense periphery on T2 weighted image. Extended hyperintense area was observed around this lesions, which represented brain edema. On T1 weighted image, the central core was demonstrated hypointense and its periphery was isointense. After starting antituberculous therapy, MRI revealed paradoxical expansion of left temporal lesion and neurological symptoms worsened temporarily, but, eventually the intracranial lesions diminished in size and disappeared, and the symptoms improved. So we diagnosed her as having intracranial tuberculoma. By long-term following up with MRI, we observed that the central core of the left temporal tuberculoma had changed gradually to hypointense on T2 weighted image and hyperintense on T1 weighted image respectively. We thought that the change of the central core on MRI represented organization of caseated necrosis.


Subject(s)
Brain/pathology , Magnetic Resonance Imaging , Tuberculoma, Intracranial/diagnosis , Antitubercular Agents/administration & dosage , Female , Follow-Up Studies , Humans , Isoniazid/administration & dosage , Middle Aged , Necrosis , Rifampin/administration & dosage , Streptomycin/administration & dosage , Time Factors , Tuberculoma, Intracranial/drug therapy
20.
Rinsho Shinkeigaku ; 38(12): 1054-8, 1998 Dec.
Article in Japanese | MEDLINE | ID: mdl-10349348

ABSTRACT

A 39-year-old female, who had splenectomy for idiopathic thrombocytopenic purpura (ITP) in 1988, was admitted to our hospital with high fever, headache, and loss of consciousness on November 29,1997. Neck stiffness and Kernig's sign were present. Examination of cerebrospinal fluid showed pleocytosis up to 506 cells/mm3 with 89% of polymorphonuclear cells and elevated protein to 1,135 mg/dl, and absence of glucose, Streptococcus pneumoniae phagocytosis was detected in the fluid. We diagnosed her as having pneumococcal meningitis as overwhelming postsplenectomy infection (OPSI) syndrome. After administration of dexamethasone (8 mg/day), cefotaxime (4 g/day), and ampicillin (6 g/day), she survived without any complications. Splenectomized patients have been recognized as immunocompromized hosts, and carry high morbidity and mortality risk from fulminant bacterial infections. Therefore, emergency treatment is important to reduce high mortality in such infections. We present an adult case of OPSI syndrome which occurred as pneumococcal meningitis, and we would like to emphasize the importance of prompt use of corticosteroids and high dose of sensitive antibiotics before DIC may occur during the course of illness.


Subject(s)
Meningitis, Pneumococcal/drug therapy , Postoperative Complications/drug therapy , Splenectomy , Adult , Ampicillin/administration & dosage , Anti-Inflammatory Agents/administration & dosage , Cefotaxime/administration & dosage , Cephalosporins/administration & dosage , Dexamethasone/administration & dosage , Drug Therapy, Combination/administration & dosage , Female , Humans , Immunocompromised Host , Penicillins/administration & dosage , Purpura, Thrombocytopenic, Idiopathic/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...